AU3719699A - Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-(4-(4pyridyl)benzoyl) piperazine - Google Patents
Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-(4-(4pyridyl)benzoyl) piperazine Download PDFInfo
- Publication number
- AU3719699A AU3719699A AU37196/99A AU3719699A AU3719699A AU 3719699 A AU3719699 A AU 3719699A AU 37196/99 A AU37196/99 A AU 37196/99A AU 3719699 A AU3719699 A AU 3719699A AU 3719699 A AU3719699 A AU 3719699A
- Authority
- AU
- Australia
- Prior art keywords
- chloronaphth
- ylsulphonyl
- piperazine
- benzoyl
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9809350 | 1998-05-02 | ||
| GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
| PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3719699A true AU3719699A (en) | 1999-11-23 |
Family
ID=10831311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU37196/99A Abandoned AU3719699A (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-(4-(4pyridyl)benzoyl) piperazine |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1084118A1 (xx) |
| JP (1) | JP2002513789A (xx) |
| KR (1) | KR20010043216A (xx) |
| CN (1) | CN1308629A (xx) |
| AU (1) | AU3719699A (xx) |
| BR (1) | BR9910176A (xx) |
| CA (1) | CA2331041A1 (xx) |
| EE (1) | EE200000638A (xx) |
| GB (1) | GB9809350D0 (xx) |
| HU (1) | HUP0102394A3 (xx) |
| IL (1) | IL139405A0 (xx) |
| NO (1) | NO20005498L (xx) |
| PL (1) | PL343705A1 (xx) |
| SK (1) | SK16522000A3 (xx) |
| WO (1) | WO1999057112A1 (xx) |
| ZA (1) | ZA200006036B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9815377A (pt) | 1997-09-30 | 2001-01-16 | Daiichi Pharmaceutical Co Ltda | Derivados de sulfonil |
| TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
| PT1569912E (pt) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| CA2287292A1 (en) * | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
| BR9815377A (pt) * | 1997-09-30 | 2001-01-16 | Daiichi Pharmaceutical Co Ltda | Derivados de sulfonil |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005498D0 (no) | 2000-11-01 |
| NO20005498L (no) | 2000-11-01 |
| SK16522000A3 (sk) | 2001-05-10 |
| EP1084118A1 (en) | 2001-03-21 |
| CN1308629A (zh) | 2001-08-15 |
| PL343705A1 (en) | 2001-08-27 |
| IL139405A0 (en) | 2001-11-25 |
| EE200000638A (et) | 2002-04-15 |
| HUP0102394A2 (hu) | 2001-12-28 |
| ZA200006036B (en) | 2002-01-25 |
| HUP0102394A3 (en) | 2003-01-28 |
| KR20010043216A (ko) | 2001-05-25 |
| JP2002513789A (ja) | 2002-05-14 |
| GB9809350D0 (en) | 1998-07-01 |
| WO1999057112A1 (en) | 1999-11-11 |
| CA2331041A1 (en) | 1999-11-11 |
| BR9910176A (pt) | 2001-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6022869A (en) | Aminoheterocyclic compounds with antithrombotic/anticoagulant effect | |
| EP1477175B1 (en) | Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient | |
| RU2067975C1 (ru) | 1,2-дигидро-2-оксопиридины, их физиологически приемлемые соли и фармацевтическая композиция | |
| AU754747B2 (en) | Heterocyclic derivatives which inhibit factor XA | |
| TWI232105B (en) | Novel compounds and their preparation process and pharmaceutical formulation containing the same | |
| EP3421036A1 (en) | Multisubstituted aromatic compounds as serine protease inhibitors | |
| EP2138482A1 (en) | Bicyclic heterocyclic compound | |
| JP2023518356A (ja) | Ｃｏｖｉｄ－１９関連状態の治療のための方法 | |
| US6326386B1 (en) | Benzamide derivatives as thrombin inhibitors | |
| EP1015449B1 (en) | (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors | |
| JP2002513782A (ja) | Ｘａ因子を阻害する複素環誘導体 | |
| AU3719699A (en) | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-(4-(4pyridyl)benzoyl) piperazine | |
| AU757738B2 (en) | Heterocyclic derivatives as inhibitors of Factor Xa | |
| WO2001017990A1 (en) | Heterocyclic derivatives as inhibitors of factor xa | |
| MXPA00010676A (en) | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl]piperazine | |
| CZ20004037A3 (cs) | Forma l-(6-chlornaft-2-ylsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazinu se zmenšenu velikostí částic a farmaceutická kompozice tuto formu obsahující | |
| EP1117644A1 (en) | Benzamide derivatives as thrombin inhibitors | |
| WO2000078749A1 (en) | Sulfonamide derivative as factor xa inhibitor | |
| MXPA01008067A (es) | Derivados heterociclicos como inhibidores del factor xa | |
| MXPA00000505A (en) | Heterocyclic derivatives which inhibit factor xa | |
| MXPA99003712A (en) | HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |